Physician profile
Eric Robert Mong
NPI 1902465958
$11,789.66
in general payments reported to CMS, 2019-2025
25 companies · $2,424 in 2025
The $2,424 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.07 · 2021: $1,532 · 2022: $319 · 2023: $5,968 · 2024: $1,526 · 2025: $2,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,999 · Travel and Lodging: $3,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,999.37 |
| Travel and Lodging | $3,918.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $3,213.84 | 2023 | Northstar, Mariner Mis, Mariner |
| Aesculap, INC. | $2,418.41 | 2023-2025 | Progav 2.0, No Applicable Marketed Product Name, M.Blue |
| Medtronic, INC. | $1,176.69 | 2021 | |
| Aesculap Implant Systems, LLC | $532.98 | 2023 | Activl |
| Stryker Corporation | $514.84 | 2021-2025 | Adherus Autospray Dural Sealant, Universal Neuro 3, Na |
| Depuy Synthes Sales INC. | $431.16 | 2024-2025 | Synthecel, Matrixneuro |
| Kerecis Limited | $340.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Livanova USA, INC. | $336.64 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Novocure INC. | $322.56 | 2024-2025 | Optune Gio, Optune |
| Boston Scientific Corporation | $313.62 | 2022-2023 | |
| Si-Bone, INC. | $293.59 | 2021-2023 | |
| Integra Lifesciences Corporation | $254.39 | 2021-2025 | Codman Hakim, Cusa Clarity, Codman Certas |
| Innovasis INC | $245.10 | 2022-2024 | |
| Kuros Biosciences USA, INC | $243.56 | 2024-2025 | Magnetos |
| Coloplast Corp | $164.83 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $163.34 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Alphatec Spine, INC | $147.80 | 2023 | |
| Mimedx Group, INC. | $144.14 | 2025 | |
| Augmedics INC. | $137.68 | 2024 | Xvision |
| Curonix LLC | $133.04 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merck Sharp & Dohme LLC | $73.37 | 2024 | Welireg |
| Longeviti Neuro Solutions INC | $70.00 | 2023 | |
| Zimvie INC. | $56.33 | 2023-2024 | |
| Azurity Pharmaceuticals, INC. | $40.51 | 2023 | Gliadel |
| Medtronic USA, INC. | $21.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.